Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome

  • Eliano Pio Navarese
  • , Volker Schulze
  • , Felicita Andreotti
  • , Mariusz Kowalewski
  • , Michalina Kołodziejczak
  • , David E. Kandzari
  • , Tienush Rassaf
  • , Bartosz Gorny
  • , Maximilian Brockmeyer
  • , Christian Meyer
  • , Sergio Berti
  • , Jacek Kubica
  • , Malte Kelm
  • , Marco Valgimigli
  • Heinrich Heine University Düsseldorf
  • Systematic Investigation and Research on Interventions and Outcomes (SIRIO) MEDICINE research network
  • Piedmont Heart Institute
  • National Research Council of Italy
  • Erasmus University Rotterdam

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).
Lingua originaleInglese
pagine (da-a)201-213
Numero di pagine13
RivistaJACC: Cardiovascular Interventions
Volume8
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • GP IIb/IIIa inhibitor
  • acute coronary syndrome
  • bivalirudin
  • heparin
  • meta-analysis

Fingerprint

Entra nei temi di ricerca di 'Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome'. Insieme formano una fingerprint unica.

Cita questo